Dawn B Beaulieu Selected Research

Dawn B Beaulieu Research Topics

13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2023 - 01/2009
11	Crohn Disease (Crohn's Disease) 10/2021 - 01/2009
11	Ulcerative Colitis 10/2021 - 02/2009
5	Infections 01/2022 - 03/2007
3	Colitis 10/2023 - 01/2013
2	Histoplasmosis 01/2019 - 06/2016
1	Premature Birth (Birth, Premature) 10/2023
1	Ileitis 10/2023
1	Dysbiosis 11/2018
1	Pneumonia (Pneumonitis) 11/2018
1	Mental Disorders (Mental Disorder) 12/2017
1	Overweight 01/2017
1	Sarcopenia 01/2017
1	Invasive Fungal Infections 06/2016
1	Inflammation (Inflammations) 10/2013

4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 06/2016
3	Immunologic Factors (Immunomodulators)IBA 10/2023 - 03/2007
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2018
2	vedolizumabIBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 01/2016
2	CytokinesIBA 01/2019 - 01/2016
2	Amino Acids FDA Link 01/2018 - 01/2016
2	Arginine (L-Arginine)FDA Link 01/2016 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2016 - 10/2013
2	Infliximab (Remicade)FDA Link 07/2010 - 12/2009
1	tofacitinibIBA 10/2021
1	Nicotine FDA Link 01/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	SteroidsIBA 11/2018
1	VaccinesIBA 01/2018
1	LipidsIBA 01/2018
1	A-factor (Streptomyces)IBA 12/2017
1	EnzymesIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2015
1	SodiumIBA 10/2013
1	Dextrans (Dextran)FDA Link 10/2013
1	OxazoloneIBA 01/2013
1	Chemokine CCL11IBA 01/2013
1	Dextran SulfateIBA 01/2013
1	GlucocorticoidsIBA 01/2009
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007

10	Therapeutics 10/2023 - 01/2009
2	Biological Therapy 01/2020 - 01/2018
1	Injections 01/2020
1	Fecal Microbiota Transplantation 11/2018
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2017
1	Contraindications 08/2015
1	Aftercare (After-Treatment) 02/2015
1	Colectomy 02/2009